0 TSX News - November 20, 2018M Split Corp. Monthly Dividend Declared for Class I Preferred SharesTORONTO, Nov. 20, 2018 (GLOBE NEWSWIRE) — M Split Corp. (“M Split”) declares its monthly distribution of $0.03125 per share […]Read More
0 TSX News - November 20, 2018Canadian Banc Corp. Monthly Dividend Declaration for Class A & Preferred ShareTORONTO, Nov. 20, 2018 (GLOBE NEWSWIRE) — Canadian Banc Corp. (The “Company”) declares its monthly distribution of $0.09208 for each […]Read More
0 TSX News - November 20, 2018Prime Dividend Corp. Monthly Dividend Declaration for Class A & Preferred ShareTORONTO, Nov. 20, 2018 (GLOBE NEWSWIRE) — Prime Dividend Corp. (The “Company”) declares its monthly distribution of $0.05125 for each […]Read More
0 TSX News - November 20, 2018North American Financial 15 Split Corp. Regular Monthly Dividend Declaration for Class A & Preferred ShareTORONTO, Nov. 20, 2018 (GLOBE NEWSWIRE) — North American Financial 15 Split Corp. (The “Company”) declares its regular monthly distribution […]Read More
0 TSX News - November 20, 2018Dividend 15 Split Corp. II Regular Monthly Dividend Declaration for Preferred ShareTORONTO, Nov. 20, 2018 (GLOBE NEWSWIRE) — Dividend 15 Split Corp. II (“Dividend 15 II”) declares its regular monthly distribution […]Read More
0 TSX News - November 20, 2018Financial 15 Split Corp. Regular Monthly Dividend Declaration for Class A & Preferred ShareTORONTO, Nov. 20, 2018 (GLOBE NEWSWIRE) — Financial 15 Split Corp. (“Financial 15”) declares its regular monthly distribution of $0.12570 […]Read More
0 TSX News - November 20, 2018Alderon’s Strategic Partner, HBIS, Meets Newfoundland and Labrador Premier, Hon. Dwight Ball, as Part of Successful China Mission with Stakeholders of the High-Grade Kami Iron Ore ProjectMONTREAL, Nov. 20, 2018 (GLOBE NEWSWIRE) — Alderon Iron Ore Corp. (TSX: IRON) (“Alderon” or the “Company”) is pleased to […]Read More
0 TSX News - November 20, 2018ProMIS Neurosciences Issues Year-to-Date Update, Highlighting 2018 AccomplishmentsDevelopment of therapeutic antibodies for Alzheimer’s disease, Parkinson’s disease and ALS are top priorities for drug development and potential partnering […]Read More
0 TSX News - November 20, 2018IMV Moves to Develop DPX-Survivac as Monotherapy for Recurrent Ovarian CancerIMV Will Host an Investor Call Today at 8:00 a.m. ET to Discuss the Updates to Its Clinical Program DARTMOUTH, […]Read More
0 TSX News - November 20, 2018Aptose to Participate in Upcoming Investor Conferences, Host Key Opinion Leader Event, and Present Data at the Upcoming ASH MeetingSAN DIEGO and TORONTO, Nov. 20, 2018 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: […]Read More